LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can zapping a few spots keep lung cancer in check?
Disease control OngoingThis trial tests whether precisely targeted radiation (SABR) to a small number of growing tumors, while continuing current drug therapy, can delay overall disease progression in people with metastatic non-small cell lung cancer. About 68 participants whose cancer has started to g…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a lighter immunotherapy schedule keep advanced cancers in check?
Disease control OngoingThis trial is for people with advanced cancers who have already responded well to 6 months of standard immunotherapy. It compares continuing the same drugs at the usual frequency versus giving them every 3 months. The goal is to see if the reduced schedule can prevent cancer prog…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New immunotherapy combo shows promise for stage IV lung cancer
Disease control OngoingThis study tests two immunotherapy drugs, durvalumab and tremelimumab, with or without chemotherapy, in 301 people with stage IV non-small cell lung cancer. The goal is to see if these drugs help patients live longer by helping their immune system fight the cancer. Participants m…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Doctors inject chemo directly into lung tumors in early trial
Disease control OngoingThis early-phase trial tests a new method to deliver the chemotherapy drug cisplatin directly into lung tumors using a bronchoscope. The goal is to find the safest dose and see if this approach can help control stage IV lung cancer. Only 16 participants are enrolled, and the main…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can tailored meals ease lung cancer treatment side effects?
Symptom relief OngoingThis study is testing whether providing medically tailored meals along with nutrition counseling can improve the health and well-being of lung cancer patients who are economically disadvantaged or from minority groups. About 299 patients from four U.S. medical centers will receiv…
Matched conditions: LUNG CANCER METASTATIC
Phase: NA • Sponsor: Tufts University • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC